Changping Zou Selected Research

retinamide

1/2007	Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer.
9/2006	Intravesical N-(4-hydroxyphenyl) retinamide and adriamycin induces apoptosis in bladder cancer.
9/2006	4-HPR modulates gene expression in ovarian cells.
9/2005	Cactus pear: a natural product in cancer chemoprevention.
8/2005	In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changping Zou Research Topics

Disease

13	Neoplasms (Cancer) 05/2010 - 01/2003
7	Ovarian Neoplasms (Ovarian Cancer) 01/2010 - 08/2005
5	Urinary Bladder Neoplasms (Bladder Cancer) 09/2006 - 06/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2014 - 01/2003
2	Carcinoma (Carcinomatosis) 09/2006 - 01/2003
2	Uterine Cervical Dysplasia 01/2003 - 05/2002
1	Spontaneous Remission 05/2010
1	Prostatic Neoplasms (Prostate Cancer) 09/2006
1	Transitional Cell Carcinoma 01/2005
1	Leiomyoma (Uterine Fibroids) 03/2004

Drug/Important Bio-Agent (IBA)

11	FenretinideIBA 12/2007 - 06/2002
7	RetinoidsIBA 12/2007 - 03/2004
5	retinamideIBA 01/2007 - 08/2005
2	TeaIBA 05/2010 - 09/2005
2	Caspase 3 (Caspase-3)IBA 01/2010 - 08/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2007 - 09/2005
2	Oral ContraceptivesIBA 01/2007 - 01/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2005 - 01/2003
2	Eflornithine (Ornidyl)FDA Link 03/2004 - 05/2002
1	Therapeutic UsesIBA 05/2010
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2010
1	PolyphenolsIBA 05/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010
1	NF-kappa B (NF-kB)IBA 01/2010
1	Laminin (Merosin)IBA 07/2009
1	Glutamic Acid (Glutamate)FDA Link 12/2007
1	MucinsIBA 01/2007
1	Hormones (Hormone)IBA 01/2007
1	VaccinesIBA 01/2007
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	naphthaleneIBA 09/2006
1	AcidsIBA 09/2006
1	Carboxylic AcidsIBA 09/2006
1	CarcinogensIBA 09/2006
1	DNA (Deoxyribonucleic Acid)IBA 09/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2006
1	EnzymesIBA 09/2006
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 09/2006
1	QuercetinIBA 09/2006
1	SmokeIBA 09/2006
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 09/2006
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 09/2006
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 03/2006
1	SolutionsIBA 09/2005
1	Annexin A4IBA 09/2005
1	Biological ProductsIBA 09/2005
1	STAT1 Transcription FactorIBA 01/2005
1	retinoic acid receptor betaIBA 01/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2005
1	InterferonsIBA 01/2005
1	PolyaminesIBA 03/2004
1	Radiation-Sensitizing AgentsIBA 06/2002
1	Angiogenesis InhibitorsIBA 05/2002
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 05/2002

Therapy/Procedure

7	Chemoprevention 05/2010 - 01/2005
2	Hysterectomy 01/2014 - 03/2004
2	Therapeutics 12/2007 - 06/2002
2	Aftercare (After-Treatment) 12/2007 - 06/2002
1	Drug Therapy (Chemotherapy) 09/2006